FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084041520> ?p ?o ?g. }

• W2084041520 endingPage "60" @default.
• W2084041520 startingPage "52" @default.
• W2084041520 abstract "The goal of this study was to determine the effect of aminoguanidine on basal macromolecular efflux from the microcirculation of the hamster cheek pouch during diabetes mellitus. We used intravital fluorescent microscopy and fluorescein isothiocyanate dextrans (FITC-dextran; mw = 70 and 20K) to examine basal macromolecular extravasation in nondiabetic hamsters, nondiabetic hamsters treated with a topical application of aminoguanidine (0.5 mM), diabetic hamsters (6–10 weeks after injection of streptozotocin), and diabetic hamsters treated with a topical application of aminoguanidine (0.5 mM). Increases in macromolecular efflux were quantitated by calculating the clearance (ml/s × 10−6) of FITC-dextran-70K and -20K. In nondiabetic hamsters, the clearance of FITC-dextran-70K and -20K remained relatively constant during the experimental period, although the clearance of FITC-dextran-70K was less than that for FITC-dextran-20K. Topical application of aminoguanidine did not alter basal permeability characteristics in nondiabetic hamsters. In diabetic hamsters, clearance of FITC-dextran-70K and -20K also remained relatively constant during the experimental period. However, the magnitude of clearance of FITC-dextran-70K and and -20K was significantly greater in diabetic compared to nondiabetic hamsters (P < 0.05). Topical application of aminoguanidine restored basal permeability characteristics of diabetic hamsters to that observed in nondiabetic hamsters. These findings suggest that acute treatment of the microcirculation in vivo with aminoguanidine ameliorates basal increases in extravasation of macromolecules during diabetes mellitus. We suggest that aminoguanidine suppresses basal macromolecular efflux in diabetic hamsters via inhibition of nitric oxide synthase. Thus, it appears that the use of aminoguanidine may be an important therapeutic approach for the treatment of diabetes-related vascular dysfunction." @default.
• W2084041520 created "2016-06-24" @default.
• W2084041520 creator A5042770255 @default.
• W2084041520 creator A5042813540 @default.
• W2084041520 date "2000-01-01" @default.
• W2084041520 modified "2023-09-27" @default.
• W2084041520 title "Aminoguanidine Suppresses Basal Macromolecular Extravasation during Diabetes Mellitus" @default.
• W2084041520 cites W1263018205 @default.
• W2084041520 cites W1841976460 @default.
• W2084041520 cites W1866346780 @default.
• W2084041520 cites W1978687268 @default.
• W2084041520 cites W1987354501 @default.
• W2084041520 cites W1991359884 @default.
• W2084041520 cites W1999175736 @default.
• W2084041520 cites W1999469916 @default.
• W2084041520 cites W2000566290 @default.
• W2084041520 cites W2001534894 @default.
• W2084041520 cites W2007880055 @default.
• W2084041520 cites W2010920613 @default.
• W2084041520 cites W2013836348 @default.
• W2084041520 cites W2023507382 @default.
• W2084041520 cites W2034699376 @default.
• W2084041520 cites W2045846314 @default.
• W2084041520 cites W2073713671 @default.
• W2084041520 cites W2074903250 @default.
• W2084041520 cites W2075100842 @default.
• W2084041520 cites W2077824574 @default.
• W2084041520 cites W2078474901 @default.
• W2084041520 cites W2087317810 @default.
• W2084041520 cites W2088193206 @default.
• W2084041520 cites W2091321868 @default.
• W2084041520 cites W2092763906 @default.
• W2084041520 cites W2101651570 @default.
• W2084041520 cites W2107376901 @default.
• W2084041520 cites W2108260545 @default.
• W2084041520 cites W2128049884 @default.
• W2084041520 cites W2138116591 @default.
• W2084041520 cites W2139093190 @default.
• W2084041520 cites W2150189466 @default.
• W2084041520 cites W2171686436 @default.
• W2084041520 cites W2171730070 @default.
• W2084041520 cites W2172084084 @default.
• W2084041520 cites W2180152260 @default.
• W2084041520 cites W2235517549 @default.
• W2084041520 cites W2282610360 @default.
• W2084041520 cites W2340948203 @default.
• W2084041520 cites W2408873099 @default.
• W2084041520 cites W2409147574 @default.
• W2084041520 cites W2411645407 @default.
• W2084041520 cites W2414806754 @default.
• W2084041520 cites W2467283763 @default.
• W2084041520 cites W2471887357 @default.
• W2084041520 doi "https://doi.org/10.1006/mvre.1999.2194" @default.
• W2084041520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10625571" @default.
• W2084041520 hasPublicationYear "2000" @default.
• W2084041520 type Work @default.
• W2084041520 sameAs 2084041520 @default.
• W2084041520 citedByCount "4" @default.
• W2084041520 countsByYear W20840415202019 @default.
• W2084041520 crossrefType "journal-article" @default.
• W2084041520 hasAuthorship W2084041520A5042770255 @default.
• W2084041520 hasAuthorship W2084041520A5042813540 @default.
• W2084041520 hasConcept C113045295 @default.
• W2084041520 hasConcept C121332964 @default.
• W2084041520 hasConcept C126322002 @default.
• W2084041520 hasConcept C134018914 @default.
• W2084041520 hasConcept C142724271 @default.
• W2084041520 hasConcept C185592680 @default.
• W2084041520 hasConcept C2777019933 @default.
• W2084041520 hasConcept C2777339698 @default.
• W2084041520 hasConcept C2778024521 @default.
• W2084041520 hasConcept C2778575167 @default.
• W2084041520 hasConcept C2779280383 @default.
• W2084041520 hasConcept C2779540182 @default.
• W2084041520 hasConcept C34439696 @default.
• W2084041520 hasConcept C55493867 @default.
• W2084041520 hasConcept C555293320 @default.
• W2084041520 hasConcept C62520636 @default.
• W2084041520 hasConcept C71924100 @default.
• W2084041520 hasConcept C91881484 @default.
• W2084041520 hasConceptScore W2084041520C113045295 @default.
• W2084041520 hasConceptScore W2084041520C121332964 @default.
• W2084041520 hasConceptScore W2084041520C126322002 @default.
• W2084041520 hasConceptScore W2084041520C134018914 @default.
• W2084041520 hasConceptScore W2084041520C142724271 @default.
• W2084041520 hasConceptScore W2084041520C185592680 @default.
• W2084041520 hasConceptScore W2084041520C2777019933 @default.
• W2084041520 hasConceptScore W2084041520C2777339698 @default.
• W2084041520 hasConceptScore W2084041520C2778024521 @default.
• W2084041520 hasConceptScore W2084041520C2778575167 @default.
• W2084041520 hasConceptScore W2084041520C2779280383 @default.
• W2084041520 hasConceptScore W2084041520C2779540182 @default.
• W2084041520 hasConceptScore W2084041520C34439696 @default.
• W2084041520 hasConceptScore W2084041520C55493867 @default.
• W2084041520 hasConceptScore W2084041520C555293320 @default.
• W2084041520 hasConceptScore W2084041520C62520636 @default.
• W2084041520 hasConceptScore W2084041520C71924100 @default.
• W2084041520 hasConceptScore W2084041520C91881484 @default.

• next